Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs

As fellow stakeholders in developing novel drug delivery in gene therapy, we greatly admire the review of Sean Dilliard and Daniel Siegwart from The University of Texas Southwestern Medical School describing passive, active and endogenous organ-targeted lipid and polymer nanoparticles. Amazing compilation!

See the full article here

Cyclodextrins: Only Pharmaceutical Excipients or Full-Fledged Drug Candidates?

What is the future of cyclodextrin: excipient or API?
A very timely review from University of Debrecen (Gyorgy PanyiFlorina Zakany, et al.) discussing #molecular targets, mechanism of action, and ongoing research in several diseases. Which do you think holds the future?

See the full article here